skip to content

Early Cancer Institute

 
Read more at: Scientists confirm precursor to most common form of oesophageal cancer – offering opportunities to catch the disease early
 3,100 patients were analysed to test whether all oesophageal adenocarcinoma arise from Barrett's oesophagus

Scientists confirm precursor to most common form of oesophageal cancer – offering opportunities to catch the disease early

15 April 2026

Findings published in Nature Medicine show the strongest evidence to date that a condition known as Barrett’s oesophagus is the starting point for all cases of oesophageal adenocarcinoma - the most common type of oesophageal cancer in the developed world - paving the way to improved early detection of the disease.


Read more at: New Cambridge Postdoctoral Fellowship awarded to rising researcher in early cancer

New Cambridge Postdoctoral Fellowship awarded to rising researcher in early cancer

14 April 2026

The new Bjorn Saven Postdoctoral Fellowship in Early Cancer Research, made possible by a generous donation from Bjorn Saven CBE, is a critical initiative to support promising scientists at a pivotal moment in their careers.


Read more at: Andreas Hadjinicolaou receives ESGE Next Generation Award 2026
Andreas Hadjinicolaou ESGE award announcement

Andreas Hadjinicolaou receives ESGE Next Generation Award 2026

14 April 2026

Dr Andreas Hadjinicolaou, Gastroenterologist and Academic Clinical Lecturer in Gastroenterology has been recognised with a Next Generation Award from the European Society of Gastrointestinal Endoscopy (ESGE).


Read more at: Cambridge Festival Methylation Mayhem game explains early cancer research
Early Cancer Institute volunteers at the Cambridge Festival 2026

Cambridge Festival Methylation Mayhem game explains early cancer research

26 March 2026

Staff and students from the Early Cancer Institute were delighted to engage with families and members of the public at the Big Biomedical Campus Open Day on Saturday 21st March.


Read more at: ECI researcher selected to attend 2026 Lindau Nobel Meeting
Lindau Nobel meetings logo

ECI researcher selected to attend 2026 Lindau Nobel Meeting

23 March 2026

In October we reported that Dr Emma Hazelwood, a postdoctoral researcher in Dr Alex Frankell’s group, had been shortlisted to be considered to attend the highly competitive and internationally renowned Lindau Nobel Laureate Meeting. We are now absolutely thrilled to announce that Emma has been chosen by the selection...


Read more at: Collaborative review highlights how cancer genomics are transforming early detection and precision prevention
Nature Genetics Logo

Collaborative review highlights how cancer genomics are transforming early detection and precision prevention

2 March 2026

A new review by clinicians and scientists from the Cambridge Stem Cell Institute and the Early Cancer Institute, University of Cambridge, highlights how advances in cancer genomics are reshaping early detection and prevention of different cancers.


Read more at: UK government announces National Cancer Plan for England

UK government announces National Cancer Plan for England

4 February 2026

Today, 4th February, is World Cancer Day and sees the announcement of the UK government's National Cancer Plan for England. The plan, shaped by an extensive call for evidence exercise, held from 4 February to 29 April 2025 with more than 11,000 responses from patients, policy makers, clinicians, researchers, health groups...


Read more at: Targeting damaged cells could improve chemotherapy for lung and ovarian cancers

Targeting damaged cells could improve chemotherapy for lung and ovarian cancers

3 February 2026

New research published today in Nature Aging by scientists at the University of Cambridge sheds light on why some lung and ovarian cancers stop responding to chemotherapy, and how this resistance might one day be prevented. Platinum-based chemotherapy is commonly used to treat non-small cell lung cancer (NSCLC) and high-...


Read more at: Rebecca Fitzgerald announced as Fellow of the AACR Academy Class of 2026

Rebecca Fitzgerald announced as Fellow of the AACR Academy Class of 2026

27 January 2026

Congratulations to ECI Director Rebecca Fitzgerald who has been elected as Fellow of the AACR Academy, Class of 2026. The Fellows of the AACR Academy was established to honour scientists, clinicians, and physician-scientists whose visionary work has reshaped the landscape of cancer research. These individuals have...


Read more at: Successful MRC Programme Award to deepen understanding of kidney cancer and identify new treatment targets
Dr Tom Mitchell

Successful MRC Programme Award to deepen understanding of kidney cancer and identify new treatment targets

18 December 2025

Congratulations to a collaborative team of researchers representing the Early Cancer Institute at the University of Cambridge, the Wellcome Sanger Institute and University College London who have been successful in applying for a highly competitive Programme Award from the Medical Research Council (MRC). The award...